Detalhe da pesquisa
1.
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
Ann Surg Oncol
; 30(11): 6401-6410, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380911
2.
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Ann Surg Oncol
; 27(Suppl 3): 979, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514803
3.
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Ann Surg Oncol
; 26(11): 3510-3516, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297674
4.
Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
AJR Am J Roentgenol
; 213(4): 953-957, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166765
5.
ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
Ann Surg Oncol
; 30(11): 6411-6412, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537482
6.
Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization.
AJR Am J Roentgenol
; 210(4): 913-917, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446680
7.
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.
Breast Cancer Res Treat
; 143(1): 135-40, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24292868
8.
Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).
Ann Surg Oncol
; 21(9): 2889-96, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788555
9.
Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.
Ann Surg Oncol
; 20(9): 2873-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23812769
10.
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.
NPJ Breast Cancer
; 7(1): 59, 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035311
11.
Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma?
Adv Radiat Oncol
; 6(6): 100764, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485762
12.
Gene expression profiling of colorectal mucinous adenocarcinomas.
Dis Colon Rectum
; 53(6): 936-43, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20485009
13.
Layilin augments integrin activation to promote antitumor immunity.
J Exp Med
; 217(9)2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539073
14.
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
NPJ Breast Cancer
; 5: 2, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30675512
15.
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
Nat Med
; 24(8): 1178-1191, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29942093
16.
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
NPJ Breast Cancer
; 4: 26, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30131975
17.
Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.
JCI Insight
; 2(14)2017 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724802
18.
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.
J Clin Invest
; 126(9): 3447-52, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525433
19.
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
J Clin Oncol
; 34(20): 2359-65, 2016 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001590
20.
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Adv Ther
; 32(12): 1237-47, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26610383